Using microarray gene expression network analyses, FLOT1 was also identified as a potential target regulated by core transcription factors related to the immunoreaction in nocturnal hemodialysis treatment in end stage renal disease patients49. The gene discussed is FLOT1; the disease is chronic kidney disease.